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Summal~ 
During viral infections, CD8 +,CD45RO + T  populations expand. These primed cells express 
abundant levels of cytoplasmic granules that contain perforin and TIA-L Recent work has suggested 
that  the majority of this  CD8 +  population  downregulates Bcl-2  protein  expression and is 
destined to undergo apoptosis. In this study we have investigated the elimination of these apoptotic 
CD8 § T  cells by both human monocyte-derived and murine bone marrow macrophages. We 
have found that these phagocytes recognize and ingest both apoptotic CD8 + and CD4 + T cells 
using an Otv33 (vitronectin receptor)/CD36/thrombospondin recognition system, with the same 
receptors being used in the recognition of apoptotic neutrophils. These data provide new evidence 
for a mechanism that enables the clearance of greatly increased populations of CD8 + effector 
cells which are found during viral infections. This enables cellular homeostasis to occur in the 
host upon resolution of viral diseases in vivo. 
S 
elected T  cell populations proliferate during viral infec- 
tions in vivo which can result in a 20-30-fold increase 
in the frequency of virus-specific cytotoxic T  lymphocyte 
precursor cells (1). This expansion can manifest itself as a 
CD8 +  lymphocytosis  accompanied by  lymphadenopathy 
which is largely accounted for by a selective increase of the 
primed CD8 +,CD45P~O +  and  to  a  lesser  extent CD4 +, 
CD45RO + populations (2). After resolution of acute infec- 
tions by viruses such as EBV, Varicella Zoster, and influenza, 
both the activated CD8 + and CD4 + T cell numbers return 
to normal levels (1-3).  This appears  to be due to apoptosis 
of the expanded populations,  a process that is closely cor- 
related with the downregulation of the bcl-2 gene product 
(4, 5). However, the mechanisms by which apoptotic T cells 
may be removed in vivo have received little attention. If dis- 
integration of apoptotic CD8 + T  cells occurred, the cyto- 
toxic granules would be released into the extracellular com- 
partment of tissues.  Although not formally proven as yet, 
it is possible  that this may lead to the nonspecific damage 
of normal healthy/uninfected cells (6). 
The usual fate of cells that undergo apoptosis in vivo is 
rapid recognition and phagocytosis by macrophages (7, 8). 
Indeed, during resolution of inflammatory responses it has 
been shown that neutrophils are eliminated by apoptosis and 
taken up by macrophages while still intact without release 
of their potentially toxic contents (7). In this study we dem- 
onstrate that  apoptotic  CD8+,CD45RO +  cells  from  pa- 
tients with acute viral infections can be recognized and in- 
gested by human monocyte-derived  macrophages in vitro and 
that these processes  may also occur in vivo. 
Materials and Methods 
Patients and Control Samples.  Heparinized peripheral blood was 
obtained from normal individuals and patients  with infectious 
mononucleosis within 10 d of the onset of symptoms. Lymph node 
biopsies were obtained from HIV-l-infected  individuals (4). 
Antibodies Used in the Study.  The CD45RA (SN130; IgG1), 
CD45RO  (UCHL1;  IgG~.) CD4 (RFT4;  IgG1), CD8 (R,  FTS; 
IgG~ or IgM), and HLA-DR mabs (R.FDR1; IgM) have  been de- 
scribed previously (4). Macrophages in lymph node sections were 
identified using  a CD68  antibody  (EBM11; Dako  Ltd.,  High 
Wycombe, UK). An antibody against perforin (PFP; IgG2b), was 
kindly provided by Professor Bo Dupont (Laboratory of Human 
Immunogenetics, Sloan-Kettering Cancer Center, New York; ref. 
1943  J. Exp.  Med.  ￿9  The Rockefeller University Press ￿9 0022-1007/94/11/1943/05  $2.00 
Volume  180  November 1994  1943-1947 9). Another cytotoxic granule protein was identified by the anti- 
body TIA-1 (IgG1;  Coulter Clone, Luton, UK). P140,  an IgG2, 
antibody that recognizes the GplIb-IIIa complex, and Sm~ (CD36), 
an IgM antibody, were gifts from Dr. Nancy Hogg (Imperial Cancer 
Research Fund, London, UK).  C6.7,  a thrombospondin-specific 
mAb of IgGt subclass was a gift from Dr. Vishva Dixit (Univer- 
sity of Michigan,  Ann  Arbor,  MI),  while  23C6  mAb  (IgG1), 
which reacts with the. c~v~3 integrin,  was  a gift from Dr.  Mike 
Horton (St. Bartholomew's Hospital, London, UK). These anti- 
bodies have been described previously (10). 
Lymphocyte Activation and  Generation of Apoptotic  CD8 + and 
CD4 § T  Cells.  T cell populations were isolated and IL-2-depen- 
dent lines were generated as described (4, 5). To induce apoptosis, 
11--2 was withdrawn and the cells were cultured for a further 48 h 
in the absence of this cytokine. To obtain apoptotic CD8 * T cells 
from patients with EBV infections,  freshly harvested cells were cul- 
tured for 24 h  without exogenous stimuli (4). 
Cell Staining.  T  cells were analyzed by two- and three-color 
immunofluorescence and analyzed on the FACScan  |  (Becton Dick- 
inson Ltd., Oxford, UK) or Cytoron Absolute (ORTHO Diag- 
nostics,  High Wycombe, UK). Cytocentrifuge preparations and 
histological sections  were stained  as described previously (4). 
To examine apoptotic cells in  tissue  sections  CD68  antibody 
(EMBll) was used to identify macrophages followed by propidium 
iodide (PI) staining.  To investigate the TIA-1 reactivity of macro- 
phage-ingested apoptotic CD8 § T  cells, cytocentrifuge prepara- 
tions were fixed in acetone incubated with TIA-1 antibody followed 
by a goat anti-mouse Ig antiserum second layer antibody labeled 
with horseradish  peroxidase (Dako Ltd.). The slides were devel- 
oped in a solution of diamino-benzidine with 1% H202, and the 
reaction was enhanced with a solution of cobalt chloride followed 
by counterstaining with  May-Grunewald-Giemsa. 
Macrophage Recognition and Blocking Studies.  The phagocytic 
assay employed has been described previously (8,  10). Inhibitors 
included mAbs Arg-Gly-Asp-Ser  (RGDS) and control Arg-Gly- 
Glu-Ser (RGES) peptides, phospho-t-serine, and control phospha- 
tidylserine (PS)-derivative phospho-D-serine, and glycerophosphoryl- 
serine,  all obtained from Sigma Chemical Co.  (Poole,  UK). 
Figure  1.  The expression of TIA-1 and perforin (PFP) by CD8* T cell populations. Three-color immunofluorescence  was performed on T cells 
isolated from normal individuals (A), patients with acute EBV infection (/3), and IL-2-dependent CD8 * T cell line established from a normal healthy 
individual (C) using CDS, CD45RO, and HLA-DR antibodies. The CD8 + bright population was gated, and the expression  of CD45RO and HLA-DR 
was determined on 10,000 cells. TIA-1 and perforin expression was determined in cytocentrifuge preparations of the CD8 + T cells from the normal 
individual (D and G), the EBV-infected  patient (E and H), and the IL-2-dependent CD8 + line (F and/); 300-500 cells were counted per slide. 
1944  Macrophages  Phagocytoze Apoptic CDS+,CD45RO + T Cells Results 
The Expression of TIA-1  and Perforin by CD8 + T  Cells. 
The CD8 + T  cell subset  of normal individuals contained 
<40/0 of cells that coexpressed both HLA-DR and CD45RO 
(Fig. 1 A). In EBV-infected patients,  50-80% of the expanded 
CD8 + pool coexpressed HLA-DR and CD45RO, indicating 
recent activation (Fig.  1 B). IL-2-dependent CD8 + cell lines 
showed a comparable CD8 + ,CD45RO + ,HLA-DR + pheno- 
type to the CD8 + T cell populations from EBV-infected pa- 
tients  (Fig.  1  C).  When CD8+,CD45RO + T  cells  from 
healthy individuals was purified, 40 _+ 12% (mean _+ SEM%) 
contained TIA-1 (Fig.  1 D) whereas 9.4  __  3.5% contained 
low levels of perforin (n  =  8;  representative result shown 
in Fig.  1 G).  In EBV-infected patients,  82.1  _+  6.5%  of 
the CD8+,CD45RO + T  cells expressed TIA-1  (Fig.  1 E) 
whereas 60.8  _+  8.7%  of cells brightly stained for perforin 
(n  --  8; Fig.  1 H), a significant increase over the values seen 
in healthy individuals (p ,s  The CD8 + IL-2-depen- 
dent line showed comparable TIA-1 and perforin reactivity 
to the CD8 §  § ceUs from EBV-infected individuals. 
The Preferential Death of CD8 +,CD45RO + T  Cells from 
EBV Patients In Vitro.  T  cells were isolated from patients 
with EBV infections and cultured in medium alone with no 
added growth factors for 3 d  (Fig.  2).  The cells were ana- 
lyzed by three-color immunofluorescence  for CD4, CD45RA, 
and CD45RO as well as for CD8, CD45RA, and CD45RO 
by flow cytometry, in parallel with the absolute cell counts 
determined on the Cytoron. CD8 + ,CD45RO + T cells were 
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shown to be preferentially susceptible to death as their numbers 
selectively decreased during the incubation period (Fig.  2). 
The Phagocytosis of Apoptotic T Cells by Macrophages.  Of 
the apoptotic CD8 + T cells, >98% retained their membrane 
integrity when used in the phagocytic assays as shown by 
trypan  blue  dye exclusion.  Freshly isolated  nonapoptotic 
CD8 + T  cells and IL-2-dependent CD8 + lines cultured in 
optimal concentrations of IL-2 were not susceptible to phago- 
cytosis by human monocyte-derived  macrophages. On removal 
of IL-2,  however, 25-40%  of the CD8 + T  cells appeared 
apoptotic after 24 h and were avidly taken up by human mono- 
cyte-derived and murine bone marrow-derived macrophages 
(Fig.  3 a).  RGDS  peptide and mAbs against macrophage 
o~v33, CD36,  and thrombospondin  (TSP) significantly in- 
hibited macrophage ingestion  of IL-2-deprived  apoptotic 
CD8 + and CD4 + T cells (Fig. 4, A  and B; p <0.001). Phos- 
phatidylserine analogues (11, 12) had no effect on the uptake 
of human apoptotic CD8 §  and CD4 + T  cells by human 
monocyte-derived macrophages (Fig.  4, A  and B).  Apop- 
totic CD8 +  cells  obtained from EBV-infected individuals 
were recognized and ingested by 35  _+ 4% of murine bone 
marrow-derived macrophages (mean +  SD%; n  =  5) that 
also employ vitronectin receptor-dependent mechanisms (7). 
This was inhibited by 2 mM RGDS peptide (to 6.4 +  1.5%) 
but not by 2 mM RGES (32.6  _+  5.4%). Rabbit polyclonal 
antiserum to murine TSP I was also inhibitory (11.8 _+ 3.1%) 
while the preimmune serum used at the same dilution was 
not (34.7  _+  1.6%). 
We found that apoptotic CD8 § T cells that had been in- 
gested by macrophages retained immunological reactivity for 
the granule component TIA-1 comparable with apoptotic 
cells tested before interaction with macrophages (Fig.  3 b). 
Macrophage Phagocytosis of  Apoptotic T Cells In Vivo.  The 
analysis of lymph nodes taken from HIV § patients with low 
CD4 numbers showed that >93% of cells in the paracortex 
were CD3+,CD8 §  and <2%  CD4 +.  PI  staining  of the 
paracortex of HIV lymph nodes revealed the presence of frag- 
mented nuclei (Fig. 3 c; asterisks). Two-color immunofluores- 
cence indicated that the majority of these apoptotic cells were 
CD8 + (not shown). Furthermore the CD68 + macrophages 
oayl  in  the paracortex  of HIV §  lymph  nodes  contained con- 
densed/degraded nuclear debris identifiable by PI staining (Fig. 
~  ......  3 c, arrows) suggesting that apoptotic T cells were being cleared 
by activated macrophages in vivo. 
oar 3  Discussion 
In this study we demonstrate that CD8 +,CD45RO § T 
cells undergoing apoptosis  are specifically  recognized and 
~i~i~::~  phagocytozed by macrophages in vitro and show that the 
CD45RA  ingested cells are intact within these phagocytes as they still 
contain cytotoxic granule proteins. Human monocyte-derived 
macrophages, the phagocytes used in this study, employ two 
surface receptors in the uptake of neutrophils undergoing apop- 
tosis:  the o~v~3 integrin and CD36 (7).  These receptors co- 
operate in binding macrophage-secreted thrombospondin, 
which forms a "bridge" between the macrophage and the 
apoptotic cell (10). We now show that that these macrophages 
employ an identical mechanism in the recognition of CD8 § 
and CD4 + T  cells undergoing apoptosis. 
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Figure  2.  The preferential death of the CD8 § ,CD45RO § population 
from EBV patients on culture without any exogenous stimuli in vitro. 
Peripheral blood mononuclear cells from a patient with EBV infection were 
cultured in medium with 10% FCS but without any other stimuli. Cells 
were harvested at the times shown and investigated for changes in viable 
CD4 + (A and B) and CD8 + (C and D) lymphocyte subsets  by three- 
color immunofluorescence using CD4 or CD8 together with CD45RA 
and CD45RO antibodies. The absolute numbers ofCD4 + (A) and CD8 + 
(C) subsets that were present at various times after culture were also deter- 
mined using a Cytoron Absolute flow cytometer. 
1945 Figure  3.  The phagocytosis of apoptotic CD8 + T cells by human macrophages. Apoptotic CD8 + T cells were incubated with human monocyte-de- 
rived macrophages for 30 min followed  by washing to remove noningested  cells. In a,  the fixed cells were then stained with hematoxylin  & eosin. 
Ingested apoptotic  cells are apparent as pyknotic masses within macrophages (a). In b, macrophages and apoptotic CD8 + T  cells were cocultured as 
above and cytocentrifuge  preparations stained for TIA-1 by immunoperoxidase  methodology. One macrophage that has ingested  numerous apoptotic 
cells is shown. Macrophages cultured without apoptotic CD8 + T cells do not contain TIA-1 (not shown) whereas those with ingested CD8 * T cells 
exhibit granular TIA-1  reactivity  (arrows).  c  shows the paracortex of a lymph node section  from a HIV + patient.  In this area, the staining of serial 
sections indicated that >93% of the cells were CD3 § ,CD8 + (not shown). Nuclei were stained with propidium iodide (orange) and macrophages were 
stained with CD68 antibody  (green).  Apoptotic CD8 +  T  cells, indicated by asterisks, are identifiable within macrophages (see arrows in c). 
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Figure  4.  The inhibition of phagocytosis  of apoptotic  T  cells by human monocyte-derived  macrophages. Apoptotic CD8 §  (A) or CD4 §  (B) T 
cells generated in vitro were interacted with human monocyte-derived  macrophages. Phagocytosis was inhibited by mAbs to CD36 (Sm~), ~x~3 inte- 
grin (23C6), and TSP (C6.7) but not by the irrelevant control antibody P140. Furthermore, RGDS peptide, but not RGES, inhibited the uptake of 
apoptotic  T  lymphocytes.  Inhibitors of phosphatidylserine-dependent  recognition  of apoptotic  cells (11, 12) such as phosphatidyl-t-serine  (depicted 
as t-serine)  and glycerophosphorylserine  had no effect; phosphatidyl-D-serine was included  as a noninhibitory control.  Similar results were obtained 
with apoptotic  CD4 + T  cells  generated in vitro (B).  The data are shown as mean percentage of macrophages ingesting apoptotic  lymphocytes  _+ 
SEM (n  =  10). 
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13_ A recent report suggests that murine peritoneal macro- 
phages elicited by thioglycollate, which employ the phos- 
phatidylserine receptor in the uptake of senescent  cells (11, 
12), may be able to recognize leukocyte surface changes that 
arise as a consequence of 24 h of culture rather than apop- 
tosis (13). In contrast, a close correlation between apoptosis 
and recognition was found when human monocyte-derived 
macrophages  that  employ  the  Otv~3/CD36/TSP  receptor 
system were used in phagocytic assays (7). Furthermore, in 
the current study, human monocyte-derived macrophages did 
not  recognize nonapoptotic T  lymphocytes from healthy 
donors despite prior culture of these cells in the absence of 
exogenous stimuli for 24 h. 
Patients with HIV infection have considerably increased 
proportions  of  CD3 +,CD8 +,CD45RO +  T  cells  in  the 
paracortex of lymph nodes that express low levels of Bcl-2 
and phenotypically resemble the CD8 + subset  from EBV 
patients (4, 14). Extensive nuclear condensation and fragmen- 
tation of cell nuclei was observed in the paracortex  of HIV § 
lymph nodes and many of these apoptotic cells were found 
within macrophages. Although these investigations do not 
address the viral specificity of the dying cells and if they are 
directed to HIV itself or other opportunistic infections, they 
do suggest that the phagocytic clearance of T  cells in vitro 
have a counterpart in vivo.  A proportion of the apoptotic 
cells observed might also have been CD4 + because HIV in- 
fection may trigger apoptosis in both resting and activated 
CD4 + T cells (15). Our data obtained from experiments in 
vitro  suggest  however,  that  both  apoptotic  CD4 §  and 
CD8 + T  cells would be recognized and phagocytozed by 
macrophages in an analogous manner. 
In conclusion, we have described a general mechanism for 
the clearance of CD8 + effector T  cells and activated CD4 + 
T  cells during the resolution of viral disease that is likely 
to  play  a  key role  in  the  safe reestablishment  of T  cell 
homeostasis in vivo. 
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